Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases: a review.
about
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development.Application of biochemical markers in development of drugs for treatment of osteoarthritis.Opportunities and challenges for the discovery and validation of proteomic biomarkers for common arthritic diseases.
P2860
Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases: a review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Application of biomarkers in t ...... tive joint diseases: a review.
@ast
Application of biomarkers in t ...... tive joint diseases: a review.
@en
type
label
Application of biomarkers in t ...... tive joint diseases: a review.
@ast
Application of biomarkers in t ...... tive joint diseases: a review.
@en
prefLabel
Application of biomarkers in t ...... tive joint diseases: a review.
@ast
Application of biomarkers in t ...... tive joint diseases: a review.
@en
P2093
P2860
P1433
P1476
Application of biomarkers in t ...... tive joint diseases: a review.
@en
P2093
P2860
P304
P356
10.1080/13547500600886115
P577
2006-11-01T00:00:00Z